GENOVESI, Domenico
 Distribuzione geografica
Continente #
EU - Europa 3.871
NA - Nord America 3.546
AS - Asia 1.753
SA - Sud America 97
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 2
Totale 9.285
Nazione #
US - Stati Uniti d'America 3.527
IT - Italia 983
SG - Singapore 761
DE - Germania 738
CN - Cina 578
IE - Irlanda 514
FI - Finlandia 387
SE - Svezia 340
UA - Ucraina 311
TR - Turchia 235
GB - Regno Unito 191
FR - Francia 163
IN - India 96
RU - Federazione Russa 91
BR - Brasile 89
AT - Austria 32
CZ - Repubblica Ceca 30
HK - Hong Kong 24
VN - Vietnam 17
BE - Belgio 14
CA - Canada 14
IR - Iran 14
RO - Romania 14
NL - Olanda 13
TW - Taiwan 9
CH - Svizzera 7
EE - Estonia 7
ES - Italia 6
EU - Europa 6
GR - Grecia 6
LV - Lettonia 5
HU - Ungheria 4
PK - Pakistan 4
AR - Argentina 3
BD - Bangladesh 3
LT - Lituania 3
MA - Marocco 3
PL - Polonia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
DK - Danimarca 2
JP - Giappone 2
MX - Messico 2
QA - Qatar 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AO - Angola 1
AU - Australia 1
BG - Bulgaria 1
CR - Costa Rica 1
DZ - Algeria 1
EC - Ecuador 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LI - Liechtenstein 1
LU - Lussemburgo 1
ME - Montenegro 1
ML - Mali 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 9.285
Città #
Chandler 662
Munich 591
Singapore 523
Dublin 511
Jacksonville 459
Helsinki 306
Ashburn 259
Princeton 217
Dearborn 210
Izmir 167
Southend 146
Nanjing 141
Santa Clara 101
The Dalles 101
Beijing 99
Wilmington 87
Altamura 86
New York 79
Ann Arbor 78
Boardman 75
Chieti 75
Cambridge 72
Rome 66
Nanchang 62
Pescara 47
Washington 41
Los Angeles 39
Woodbridge 35
Milan 32
Shenyang 31
Kunming 29
Brno 27
Jyväskylä 27
Vienna 25
Hong Kong 24
San Mateo 22
Tianjin 21
Hebei 20
Changsha 19
Ancona 18
Jiaxing 18
Bologna 17
Dong Ket 17
Leawood 17
Brussels 14
Grevenbroich 14
Napoli 14
Norwalk 14
Nuremberg 13
Guangzhou 12
Hangzhou 12
Houston 12
Jinan 12
Augusta 11
Falls Church 11
Seattle 11
Ardabil 10
Barlad 10
L'aquila 10
Banqiao 9
Naples 9
São Paulo 9
Toronto 9
Bellante 8
Frankfurt am Main 7
Monmouth Junction 7
Changchun 6
Chicago 6
Grafing 6
Lanzhou 6
London 6
Moscow 6
Mumbai 6
Ningbo 6
Palermo 6
Zhengzhou 6
Camerino 5
Catania 5
Council Bluffs 5
Hefei 5
Padova 5
Riga 5
Rio de Janeiro 5
San Vito Chietino 5
Amsterdam 4
Caserta 4
Francavilla Al Mare 4
Kocaeli 4
Livorno 4
Orange 4
Ottawa 4
Pavia 4
Pisa 4
Romola 4
Shanghai 4
Taranto 4
Turin 4
Alatri 3
Auburn Hills 3
Badia Calavena 3
Totale 6.098
Nome #
Guida per la Contornazione dei linfonodi in Radioterapia 682
Assessment of bowel and anal sphincter function after neoadjuvant chemoradiotherapy in locally advanced rectal cancer 238
Developing a Decision-making Model Based on an Interdisciplinary Oncological Care Group for the Management of Colorectal Cancer 226
Parotid glands in whole-brain radiotherapy: 2D versus 3D technique for no sparing or sparing 224
Prognostic impact of hemoglobin level and other factors in patients with high-grade gliomas treated with postoperative radiochemotherapy and sequential chemotherapy based on temozolomide: a 10-year experience at a single institution 221
Clinical outcomes in elderly rectal cancer patients treated with neoadjuvant chemoradiotherapy: impact of tumor regression grade Tumor regression grade after neoadjuvant chemoradiotherapy in elderly rectal cancer patients 215
Postoperative 5-FU based Radiochemotherapy in Rectal Cancer: Retrospective Long Term Results and Prognostic Factors of a Pooled Analysis on 1,338 Patients. 207
Serum Lipidomic study reveals potential early biomarkers for predicting response to chemoradiotherapy in advanced rectal cancer: A pilot study 129
Performance of diffusion-weighted magnetic resonance imaging at 3.0T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy 126
Abeta(1-42) stimulated T cells express P-PKC-delta and P-PKC-zeta in Alzheimer disease. 124
A multidisciplinary group for prostate cancer management: A single institution experience 123
Advances in Lipidomics for Cancer Biomarkers Discovery 115
Reproducibility of rectal tumor volume delineation using diffusion-weighted MRI: Agreement on volumes between observers 108
Early nutritional support in head and neck: survey of Italian radiation oncologists/otolaryngologists 103
Involvement of cyclic-nucleotide response element-binding family members in the radiation response of Ramos B lymphoma cells 102
Hippocampal sparing approach in fractionated stereotactic brain VMAT radio therapy: A retrospective feasibility analysis 101
Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients 100
PO-1074 Radiotherapy and immuno-check point inhibitors for brain metastases. A mono-institutional analysis 100
Tumor detectability and conspicuity comparison of standard b1000 and ultrahigh b2000 diffusion-weighted imaging in rectal cancer 95
Effects of preoperative radiochemotherapy with capecitabine for resectable locally advanced rectal cancer in elderly patients 93
Magnetic resonance imaging (MRI) compared with computed tomography (CT) for interobserver agreement of gross tumor volume delineation in pancreatic cancer: a multi-institutional contouring study on behalf of the AIRO group for gastrointestinal cancers 93
Hippocampal sparing in stereotactic radiotherapy for brain metastases: To contour or not contour the hippocampus? 92
Delineating brachial plexus, cochlea, pharyngeal constrictor muscles and optic chiasm in head and neck radiotherapy: a CT-based model atlas 90
Retrospective long-term results and prognostic factors of postoperative treatment for UICC stages II and III rectal cancer 89
Development of a contouring guide in three different head set-ups for hippocampal sparing radiotherapy: a practical approach 88
Definition of Structures Aimed to Urinary continence and Sexual Potency using 3 Tesla-MRI: An Anatomo-Radiological Study of the Male Pelvic Floor. 88
Impact of pathological downstaging on Local Control (CL), Disease Free Survival (DFS) and Overall Survival (OS) after neoadjuvant Radio-Chemotherapy in locally advanced Rectal Cancer (Stage II-III/TNM). 87
Radiochemotherapy in Anal Cancer: cCR, clinical outcomes and quality of life using two different treatment schedules 87
Patients younger than 40years old and older than 70years old affected by ER(-)/PR(-)/HER2(-) breast cancer have low survival rates: Results of a mono-institutional retrospective analysis 87
Pre-operative radio-chemotherapy with cisplatin and 5-fluorouracil (Plafur) in locally advanced rectal cancer 86
Outcomes in patients with pT1-T2, pN0-N1 breast cancer after conservative surgery and whole-breast radiotherapy 86
Clinical Target Volume Definition in Preoperative Radiotherapy of Rectal Carcinoma: a Systematic Review 86
Predictors of local recurrence after conservative surgery and whole-breast irradiation 84
Biologically effective dose and definitive radiation treatment for localized prostate cancer. Treatment gaps do affect the risk of biochemical failure 84
Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: A multi-institutional experience 84
T2 and Diffusion weighted MRI for GTV delineation in rectal cancer: agreement between volumes. 84
The effect of delaying adjuvant radiation treatment after conservative surgery for early breast cancer 82
Inter-observer variability of clinical target volume delineation in definitive radiotherapy of neck lymph node metastases from unknown primary. A cooperative study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Group 82
PO-0797: Diffusion-weighted MRI for early assessment of tumor response in rectal cancer patients 81
Performance of diffusion-weighted Magnetic Resonance Imaging at 3.0T for early assessment tumor response in locally advanced rectal cancer patients treated with preoperative chemoradiation therapy. 81
Neoadjuvant radiochemotherapy of rectal cancer: our experience 80
MRI for Gross Tumor Volume Delineation in Pancreatic Cancer: a Multi-Institutional Contouring Study by the AIRO Study Group for Gastrointestinal Cancers 80
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 79
Evaluation of response to neoadjuvant radiochemotherapy (RTCT) treatment with multislice spiral computer tomography (MSCT) in patients with locally advanced rectal cancer (stage II-III/TNM) 78
Cyclic nucleotide response element binding protein (CREB) activation promotes survival signal in human K562 erythroleukemia cells exposed to ionising radiation/etoposide combined treatment. 77
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: A multi-institutional contouring experience 77
An imaging integration between TC and morphologic MR in Conformal Radiotherapy for Brain Tumours 76
Diffusion-weighted magnetic resonance for prediction of response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer : preliminary results of a monoinstitutional prospective study. 76
Role of microRNA in response to ionizing radiations: Evidences and potential impact on clinical practice for radiotherapy 75
Italian survey in postoperative radiation therapy for prostate carcinoma by the AIRO National Working Group on Prostate Radiotherapy: definitive results 75
MRI-based clinical-radiomics model predicts tumor response before treatment in locally advanced rectal cancer 75
Impact of PT0-PT1 on local control (LC) disease-free survival (DFS) and overall survival (OS) after neoadjuvant radio-chemotherapy treatment in locally advanced rectal cancer (stage II-III/TNM) 74
COVID-19 and radiation oncology: The experience of a two-phase plan within a single institution in central Italy 74
Prognostic impact of hemogloin level and other common prognostic factors in patients with high grade gliomas treated with postoperative radiochemotherapy and sequential chemotherapy based on temozolomide. 10 years experience of a single institution. 73
Adjuvant chemoradiotherapy in gastric cancer: A pooled analysis of the AIRO Gastrointestinal Group experience 73
Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives 73
Basics and frontiers on pancreatic cancer for radiation oncology: Target delineation, SBRT, SIB technique, MRgRT, particle therapy, immunotherapy and clinical guidelines 73
Diffusion-weighted MR Imaging for Prediction of Early Response of Locally Advanced Rectal Cancer to Chemoradiation Therapy 72
Radiotherapy in pancreatic tumors: retrospective analysis of clinical experience. 72
Interobserver variability of clinical target volume delineation in soft-tissue sarcomas. 72
T2 and Diffusion-Weighted MRI Sequences for Gross Tumor Volume Delineation in Rectal Cancer: greement between radiologist and radiation oncologist in volumes. 72
Short course accelerated radiation therapy (SHARON) in palliative treatment of advanced solid cancer in older patients: A pooled analysis 72
Pycnogenol may alleviate adverse effects in oncologic treatment 71
Multidisciplinary treatment in tumors of biliary ducts: feasibility and results of a clinical experience 71
Early percutaneous endoscopic gastrostomy and nutritional supplementation for patients with head and neck cancer: an Italian survey of head and neck radiation oncologists 71
EP-1493: T2 and Diffusion weighted MRI for GTV delineation in rectal cancer: agreement between volumes 71
Is multidisciplinary management possible in the treatment of lung cancer? A report from three Italian meetings 71
Long term results and prognostic factors in adjuvant rectal cancer: an Italian pooled analysis by gastrointestinal AIRO group 70
Preoperative T and N Staging of Colorectal Cancer: Accuracy of Contrast-enhanced Multi–Detector Row CT Colonograph—Initial Experience1 69
Human epidermal growth factor receptor-2 positivity predicts locoregional recurrence in patients with t1-t2 breast cancer. 69
Adjuvant chemoradiation in pancreatic cancer: A pooled analysis in elderly (>=75 years) patients 69
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 69
RANDOMIZED, MULTICENTER, PHASE IIB STUDY OF PREOPERATIVE CHEMORADIOTHERAPY IN T3 MID-DISTAL RECTAL CANCER: RALTITREXED + OXALIPLATIN + RADIOTHERAPY VERSUS CISPLATIN + 5-FLUOROURACIL + RADIOTHERAPY 68
Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study 68
Biologically effective dose and breast cancer conservative treatment: Is duration of radiation therapy really important? 68
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 67
Supportive care protocol and evaluation of side effects during radiotherapy concomitant to cetuximab in locally advanced head and neck cancer: a monoinstitutional experience. 66
Delineating organs at risk in radiation therapy 66
Role of upper abdominal reirradiation for gastrointestinal malignancies: a systematic review of cumulative dose, toxicity, and outcomes on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 66
Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study 64
Using the bolus in post-mastectomy radiation therapy (PMRT): A national survey on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Breast Cancer Group 64
Diffusion-weighted MRI for early assessment of tumor response in rectal cancer patients. 63
Qualitative and quantitative comparison of ultrahigh b2000 versus b1000 diffusion-weighted imaging in rectal cancer. 62
Phase I-II Study of Short-course Accelerated Radiotherapy (SHARON) for Palliation in Head and Neck Cancer 61
Cone-beam computed tomography for organ motion evaluation in locally advanced rectal cancer patients 61
Interval between breast-conserving surgery and start of radiation therapy in early-stage breast cancer is not predictive of local recurrence: A single-institution experience 60
Multi-omics staging of locally advanced rectal cancer predicts treatment response: a pilot study 59
A controlled study of a lecithinized delivery system of curcumin (Meriva®) to alleviate the adverse effects of cancer treatment 59
Neoadjuvant radiochemotherapy in the treatment of mid low locally advanced rectall carcinoma phase II preliminary results 59
A randomized in vitro evaluation of transient and permanent cardiac implantable electronic device malfunctions following direct exposure up to 10 Gy 59
Quality of life in early breast cancer patients: A prospective observational study using the FACT-B questionnaire 58
EP-1647 Neoadjuvant chemoradiotherapy in elderly rectal cancer patients in a mono-institutional experience 57
Palliative short-course radiotherapy in advanced pelvic cancer: A phase II study (SHARON project) 57
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 57
Impact of waiting time before radiation treatment after breast cancer surgery: retrospective cohort analysis with fractional polynomials 56
Treatment Intensification for Locally Advanced Rectal Cancer: Impact on Pathological Complete Response and Outcomes 56
Prognostic impact of triple negative phenotype in conservatively treated breast cancer 54
PO-1137 A prospective study on Quality of life in patients treated with radiotherapy for early breast cancer 53
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)–cT3 rectal cancer 51
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2 50
Totale 9.191
Categoria #
all - tutte 39.228
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.228


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020180 0 0 0 0 0 0 0 0 0 0 159 21
2020/2021752 91 15 108 20 34 137 16 67 66 43 101 54
2021/2022533 20 21 14 46 45 27 18 49 45 17 59 172
2022/20231.822 142 282 128 185 181 316 106 155 201 31 42 53
2023/20241.158 87 44 72 38 71 404 177 72 6 28 25 134
2024/20252.630 116 441 338 44 128 261 396 262 447 142 55 0
Totale 9.718